Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Cudarolimab

Cudarolimab
Cudarolimab (IBI101) is a fully human monoclonal antibody targeting OX40 (CD134), a costimulatory molecule expressed by activated immune cells. By inhibiting the interaction between OX40 and its ligand OX40L, Cudarolimab demonstrates antitumor activity, making it relevant for cancer research [1].
Catalog No. T77153Cas No. 2244739-29-3
Select Batch
Concentration:5.66 mg/mL
Contact us for more batch information

Resource Download

Cudarolimab

Catalog No. T77153Cas No. 2244739-29-3

Cudarolimab (IBI101) is a fully human monoclonal antibody targeting OX40 (CD134), a costimulatory molecule expressed by activated immune cells. By inhibiting the interaction between OX40 and its ligand OX40L, Cudarolimab demonstrates antitumor activity, making it relevant for cancer research [1].
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$289In Stock
5 mg$753In Stock
10 mg$1,180In Stock
25 mg$1,780In Stock
50 mg$2,380In Stock
100 mg$3,230In Stock
Bulk & Custom
Add to Cart
Questions
View More

Product Introduction

Bioactivity
Description
Cudarolimab (IBI101) is a fully human monoclonal antibody targeting OX40 (CD134), a costimulatory molecule expressed by activated immune cells. By inhibiting the interaction between OX40 and its ligand OX40L, Cudarolimab demonstrates antitumor activity, making it relevant for cancer research [1].
Chemical Properties
Cas No.2244739-29-3
Storage & Solubility Information
Storagestore at low temperature | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Cudarolimab | purchase Cudarolimab | Cudarolimab cost | order Cudarolimab